Gestational Trophoblastic Disease (GTD)

Cancer specialists diagnose and develop treatment plans for gestational trophoblastic disease (GTD) using the latest tests and procedures at the Abramson Cancer Center.

At Penn Medicine's Abramson Cancer Center, patients with gestational trophoblastic disease (GTD) receive their care from a multidisciplinary team of nationally recognized experts in the diagnosis, treatment and research of gynecologic cancer.

As part of the Abramson Cancer Center, the Jordan Center for Gynecologic Cancers is a center that combines the expertise of Penn Medicine physicians and scientists. At Penn, we are pioneers in gynecologic oncology and have a national reputation for outstanding patient care and innovative GTD treatment approaches. U.S. News & World Report consistently ranks Penn among the best in the nation for cancer and women's health services.

Oncology Navigators

Every step of cancer treatment, from a cancer diagnosis and treatment, to forming a survivorship plan, comes with different needs and issues that should be addressed.

Oncology navigators are committed to making sure every patient experience is as comfortable as possible. They are experts in navigating complex health care situations and serve as a consistent point of contact and a reliable source for advice, support and direction for patients and families.

Learn more about Oncology Navigators at the Abramson Cancer Center.